Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Experts create quality improvement blueprint to reduce repetitive lab tests for hospitalized patients

Experts create quality improvement blueprint to reduce repetitive lab tests for hospitalized patients

Powering up fat cells could help acute myeloid leukemia patients

Powering up fat cells could help acute myeloid leukemia patients

Researchers develop novel blood analyzer to improve anemia detection

Researchers develop novel blood analyzer to improve anemia detection

FDA approves Verzenio for advanced metastatic breast cancer

FDA approves Verzenio for advanced metastatic breast cancer

Iron supplements for low birth weight babies can prevent behavioral problems at school age

Iron supplements for low birth weight babies can prevent behavioral problems at school age

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Metabolism can impact host's susceptibility to develop malaria

Metabolism can impact host's susceptibility to develop malaria

“Super malaria” resistant to standard medications in South East Asia

“Super malaria” resistant to standard medications in South East Asia

New syndrome caused by biallelic mutations predisposes the body to tumors

New syndrome caused by biallelic mutations predisposes the body to tumors

CWRU professor wins $3.9 million NIH grant to identify countermeasures against chemical hazards

CWRU professor wins $3.9 million NIH grant to identify countermeasures against chemical hazards

Researchers investigate link between thyroid hormone and red blood cell production

Researchers investigate link between thyroid hormone and red blood cell production

Bacterial infections may trigger dysregulation of blood formation

Bacterial infections may trigger dysregulation of blood formation

Living near newly built roads in Ethiopia linked to higher rates of infant mortality

Living near newly built roads in Ethiopia linked to higher rates of infant mortality

Self-powered, paper-based electrochemical devices detect biomarkers and identify diseases

Self-powered, paper-based electrochemical devices detect biomarkers and identify diseases

Study provides insight into development of red blood cells

Study provides insight into development of red blood cells

Medical experts explore different ways to enhance situation of patients with  myelodysplastic syndromes

Medical experts explore different ways to enhance situation of patients with myelodysplastic syndromes

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

UBC researchers develop method to quickly and sensitively assess malaria progression

UBC researchers develop method to quickly and sensitively assess malaria progression

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod

New drug Idhifa for patients with refractory acute myeloid leukemia (AML) gets FDA nod